
News|Articles|December 8, 2025
Low-pg/mL quantification of TL 13-112, a proteolysistargeting chimera (PROTAC) in rat plasma
Author(s)SCIEX
This technical note demonstrates a highly sensitive, robust and rapid workflow to quantify TL 13-112, a selective ALK degrader, and its inactive control, TL 13-110, in rat plasma using a high-end triple quadrupole mass spectrometer.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
2
Top 10 BioPharm International Articles of 2025
3
FAQ: Understanding Biosimilars, Biobetters, and Interchangeability
4
Abzena Discusses Novel Approaches to Bioconjugation: Part One of Three
5